Cross-Sectional Survey Finds 62% Weaker Impulsivity-Violence Link Among Current GLP-1 Users

Researchers analyzed self-reported data from a national sample, focusing on validated scales for impulsivity, alcohol use, and offending behaviors that included assault and robbery. Current GLP-1 users showed attenuated relationships between established risk factors and violent acts compared with former users, while overall prevalence of violence remained low. The study was observational and relied entirely on retrospective self-reports collected at a single time point. The design cannot establish temporality or rule out confounding by indication, as individuals prescribed GLP-1 agonists differ systematically in metabolic and psychiatric profiles from non-users. Related work in JAMA Psychiatry has documented reduced alcohol craving with semaglutide, suggesting possible effects on reward circuitry, yet no mechanism for violence reduction has been isolated. Next steps require longitudinal cohorts or randomized trials that track adjudicated violent incidents before and after GLP-1 initiation, with prespecified endpoints and active control groups. Without such data, any public-health inference about reduced violent behavior remains speculative.